Oral and Maxillofacial Tumors
Conditions
Interventions
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who were diagnosed as oral and maxillofacial tumors by pathology or cytology from January 1, 2021 to December 31, 2021; 2. Aged 18 to 80 years old, with basic cognitive ability; 3. Karnofsky (KPS) functional status score >=60 points, expected to survive for more than 3 months; 4. Those who have no severe heart, liver, brain, kidney and other organic damage and bone marrow hematopoietic dysfunction; 5. Check blood routine before chemotherapy, and evaluate patients whose bone marrow suppression score is 0 according to WHO's grading standard for side effects of chemotherapy; 6. The chemotherapy regimen is limited to the initial chemotherapy and the TPF regimen (docetaxel + cisplatin + 5-Fu) patients will not receive other chemotherapy drugs or concurrent radiotherapy during chemotherapy; 7. Sign the informed consent and get the approval of the ethics committee.
Exclusion criteria
Exclusion criteria: 1. Complicated with hematological tumor; 2. People with mental illness; 3. Pregnant women; 4. Patients with myelosuppression before chemotherapy; 5. Patients with implanted on-demand pacemakers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Myelosuppression grade;White blood cell count;Neutrophil count;Red blood cell count;Anti-myelosuppressive medication;Platelet count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life;cancer related fatigue;TCM body constitution;Comfort; | — |
Countries
China
Contacts
Public ContactHou Lili
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed